Dr. Roberto Caricchio, M.D

NPI: 1376708032
Total Payments
$204,480
2024 Payments
$22,392
Companies
9
Transactions
46
Medicare Patients
480
Medicare Billing
$51,486

Payment Breakdown by Category

Research$154,777 (75.7%)
Consulting$44,002 (21.5%)
Travel$4,782 (2.3%)
Food & Beverage$918.49 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $154,777 2 75.7%
Consulting Fee $44,002 14 21.5%
Travel and Lodging $4,782 7 2.3%
Food and Beverage $918.49 23 0.4%

Payments by Type

Research
$154,777
2 transactions
General
$49,703
44 transactions

Top Paying Companies

Company Total Records Latest Year
Eli Lilly and Company $154,777 2 $0 (2021)
ABBVIE INC. $14,192 10 $0 (2024)
GlaxoSmithKline, LLC. $10,558 8 $0 (2023)
Merck Sharp & Dohme LLC $8,063 5 $0 (2024)
AstraZeneca Pharmaceuticals LP $7,808 10 $0 (2023)
Janssen Biotech, Inc. $5,945 8 $0 (2019)
Sobi, Inc $3,000 1 $0 (2021)
Novartis Pharmaceuticals Corporation $110.88 1 $0 (2024)
Amgen Inc. $24.86 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $22,392 17 ABBVIE INC. ($14,192)
2023 $1,039 3 GlaxoSmithKline, LLC. ($975.00)
2022 $12,175 11 AstraZeneca Pharmaceuticals LP ($7,744)
2021 $162,918 6 Eli Lilly and Company ($154,766)
2020 $11.00 1 Eli Lilly and Company ($11.00)
2019 $5,945 8 Janssen Biotech, Inc. ($5,945)

All Payment Transactions

46 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/17/2024 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $24.86 General
Category: Oncology
11/15/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $110.88 General
11/11/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $7,735.00 General
11/11/2024 Merck Sharp & Dohme LLC Travel and Lodging Cash or cash equivalent $150.00 General
10/23/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $64.66 General
10/23/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $59.27 General
10/23/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $54.55 General
06/21/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $13,975.00 General
05/02/2024 ABBVIE INC. Food and Beverage In-kind items and services $22.11 General
05/02/2024 ABBVIE INC. Food and Beverage In-kind items and services $17.39 General
05/02/2024 ABBVIE INC. Food and Beverage In-kind items and services $8.23 General
05/02/2024 ABBVIE INC. Food and Beverage In-kind items and services $7.62 General
05/01/2024 ABBVIE INC. Food and Beverage In-kind items and services $106.92 General
05/01/2024 ABBVIE INC. Food and Beverage In-kind items and services $22.11 General
05/01/2024 ABBVIE INC. Food and Beverage In-kind items and services $16.42 General
05/01/2024 ABBVIE INC. Food and Beverage In-kind items and services $9.06 General
05/01/2024 ABBVIE INC. Food and Beverage In-kind items and services $7.62 General
12/13/2023 GlaxoSmithKline, LLC. BENLYSTA (Biological) Consulting Fee Cash or cash equivalent $975.00 General
Category: IMMUNOLOGY
11/12/2023 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Food and Beverage In-kind items and services $31.28 General
Category: Inflammation and Autoimmunity
10/26/2023 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Food and Beverage In-kind items and services $32.84 General
Category: Inflammation and Autoimmunity
12/04/2022 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Consulting Fee Cash or cash equivalent $3,759.00 General
Category: Inflammation and Autoimmunity
11/12/2022 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Food and Beverage In-kind items and services $54.74 General
Category: Inflammation and Autoimmunity
11/09/2022 GlaxoSmithKline, LLC. BENLYSTA (Biological) Consulting Fee Cash or cash equivalent $325.00 General
Category: IMMUNOLOGY
10/19/2022 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Travel and Lodging In-kind items and services $2,685.00 General
Category: Inflammation and Autoimmunity
10/19/2022 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Travel and Lodging In-kind items and services $270.97 General
Category: Inflammation and Autoimmunity

Research Studies & Clinical Trials

Study Name Company Amount Records
A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH COVID 19 INFECTION Eli Lilly and Company $154,777 2

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 103 115 $54,721 $10,170
2022 1 59 62 $17,170 $4,463
2021 3 105 142 $34,220 $13,375
2020 8 213 259 $57,115 $23,477
Total Patients
480
Total Services
578
Medicare Billing
$51,486
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 58 70 $27,366 $4,922 18.0%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 20 20 $13,680 $2,901 21.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 25 25 $13,675 $2,347 17.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 30 30 $10,770 $2,417 22.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 29 32 $6,400 $2,046 32.0%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 54 83 $16,600 $6,662 40.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 24 32 $8,320 $3,546 42.6%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 27 27 $9,300 $3,168 34.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 23 26 $10,420 $4,578 43.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 38 48 $9,600 $4,040 42.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 33 33 $10,035 $3,946 39.3%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 18 20 $5,200 $2,338 45.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 15 31 $4,380 $1,946 44.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 24 27 $3,510 $1,624 46.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 19 22 $4,400 $1,431 32.5%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 12 14 $3,785 $1,360 35.9%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 11 11 $3,420 $1,294 37.8%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 20 27 $2,365 $920.61 38.9%

About Dr. Roberto Caricchio, M.D

Dr. Roberto Caricchio, M.D is a Rheumatology healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1376708032.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roberto Caricchio, M.D has received a total of $204,480 in payments from pharmaceutical and medical device companies, with $22,392 received in 2024. These payments were reported across 46 transactions from 9 companies. The most common payment nature is "" ($154,777).

As a Medicare-enrolled provider, Caricchio has provided services to 480 Medicare beneficiaries, totaling 578 services with total Medicare billing of $51,486. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Rheumatology
  • Location Worcester, MA
  • Active Since 07/22/2008
  • Last Updated 06/03/2022
  • Taxonomy Code 207RR0500X
  • Entity Type Individual
  • NPI Number 1376708032

Products in Payments

  • SAPHNELO (Biological) $7,808
  • BENLYSTA (Biological) $7,247
  • SIMPONI ARIA (Biological) $5,945
  • KINERET (Drug) $3,000
  • Blincyto (Biological) $24.86

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Rheumatology Doctors in Worcester